Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06307730
Status:
COMPLETED
Last Update Posted:
2024-03-13
First Post:
2024-03-06
Brief Title:
Application of the Recommendations of the SPLIF French Society of Infectious Pathology in a Geriatric Population on the Duration of Treatment for Bacterial Pneumonia
Sponsor:
Centre Hospitalier de Saint-Denis
Organization:
Centre Hospitalier de Saint-Denis
Study Overview
Official Title:
Duration of Antibiotic Treatment for Infectious Pneumonia in Eldery Subjects
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Pneumopathy is the leading cause of death from infectious disease in the elderly Prior to 2021 the recommended duration of antibiotic therapy for pneumonia in adults was 7 days
Two theses have shown that these recommendations were poorly applied in geriatric services Indeed the duration of treatment exceeded 7 days and less than 30 of antibiotic antibiotic treatments were re-evaluated at 72 hours
In 2021 the SPLIF published new recommendations reducing this duration to 5 days in the event of clinical improvement observed on the 3rd day of treatment These new recommendations are based on studies in which the average age of participants was 65 years However the average age of patients in geriatric short-stay departments is 847 years
In addition the geriatric population is characterized by immunosenescence pulmonary vulnerability and undernutrition raising questions about the validity of these recommendations in the geriatric population
The investigators offer a monocentric retrospective observational study of the geriatric hospital Casanova to assess the application of SPLIF recommendations in the geriatric population
Two theses have shown that these recommendations were poorly applied in geriatric services Indeed the duration of treatment exceeded 7 days and less than 30 of antibiotic antibiotic treatments were re-evaluated at 72 hours
In 2021 the SPLIF published new recommendations reducing this duration to 5 days in the event of clinical improvement observed on the 3rd day of treatment These new recommendations are based on studies in which the average age of participants was 65 years However the average age of patients in geriatric short-stay departments is 847 years
In addition the geriatric population is characterized by immunosenescence pulmonary vulnerability and undernutrition raising questions about the validity of these recommendations in the geriatric population
The investigators offer a monocentric retrospective observational study of the geriatric hospital Casanova to assess the application of SPLIF recommendations in the geriatric population
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None